| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |